These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9100284

  • 1. Evidence that rat stomach ECL cells represent the main source of circulating pancreastatin.
    Kimura K, Chen D, Lindström E, Zhao CM, Håkanson R.
    Regul Pept; 1997 Feb 26; 68(3):177-80. PubMed ID: 9100284
    [Abstract] [Full Text] [Related]

  • 2. Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia.
    Kimura K, Chen D, Lindström E, Yamada H, Zhao CM, Håkanson R.
    Regul Pept; 1997 Oct 31; 72(2-3):69-77. PubMed ID: 9652979
    [Abstract] [Full Text] [Related]

  • 3. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
    Ding XQ, Lindström E, Håkanson R.
    Pharmacol Toxicol; 1997 Jul 31; 81(1):19-25. PubMed ID: 9258980
    [Abstract] [Full Text] [Related]

  • 4. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
    Ding XQ, Lindström E, Håkanson R.
    Br J Pharmacol; 1997 Sep 31; 122(1):1-6. PubMed ID: 9298521
    [Abstract] [Full Text] [Related]

  • 5. Expression of the chromogranin A-derived peptides pancreastatin and WE14 in rat stomach ECL cells.
    Norlén P, Curry WJ, Chen D, Zhao CM, Johnston CF, Håkanson R.
    Regul Pept; 1997 Jun 18; 70(2-3):121-33. PubMed ID: 9272624
    [Abstract] [Full Text] [Related]

  • 6. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
    Chen D, Zhao CM, Norlén P, Björkqvist M, Ding XQ, Kitano M, Håkanson R.
    Cell Tissue Res; 2000 Jan 18; 299(1):81-95. PubMed ID: 10654072
    [Abstract] [Full Text] [Related]

  • 7. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach.
    Håkanson R, Ding XQ, Norlén P, Chen D.
    Gastroenterology; 1995 May 18; 108(5):1445-52. PubMed ID: 7729637
    [Abstract] [Full Text] [Related]

  • 8. Evidence that peroral calcium does not activate the gastrin-ECL-cell axis in the rat.
    Survé VV, Håkanson R.
    Regul Pept; 1998 Feb 27; 73(3):177-82. PubMed ID: 9556080
    [Abstract] [Full Text] [Related]

  • 9. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R, Ding XQ, Norlén P, Lindström E.
    Regul Pept; 1999 Mar 17; 80(1-2):1-12. PubMed ID: 10235629
    [Abstract] [Full Text] [Related]

  • 10. Depletion of enterochromaffin-like cell histamine increases histidine decarboxylase and chromogranin A mRNA levels in rat stomach by a gastrin-independent mechanism.
    Andersson K, Lindström E, Chen D, Monstein HJ, Boketoft A, Håkanson R.
    Scand J Gastroenterol; 1996 Oct 17; 31(10):959-65. PubMed ID: 8898415
    [Abstract] [Full Text] [Related]

  • 11. Gastrin-evoked secretion of pancreastatin and histamine from ECL cells and of acid from parietal cells in isolated, vascularly perfused rat stomach. Effects of isobutyl methylxanthin and alpha-fluoromethylhistidine.
    Chen D, Mårvik R, Rønning K, Andersson K, Waldum HL, Håkanson R.
    Regul Pept; 1996 Sep 09; 65(2):133-8. PubMed ID: 8884980
    [Abstract] [Full Text] [Related]

  • 12. Role of gastrin in the development of gastric mucosa, ECL cells and A-like cells in newborn and young rats.
    Björkqvist M, Dornonville de la Cour C, Zhao CM, Gagnemo-Persson R, Håkanson R, Norlén P.
    Regul Pept; 2002 Oct 15; 108(2-3):73-82. PubMed ID: 12220729
    [Abstract] [Full Text] [Related]

  • 13. Post-gastrectomy osteopenia in the rat: bone structure is preserved by retaining 10%-30% of the oxyntic gland area.
    Lehto-Axtelius D, Chen D, Surve VV, Håkanson R.
    Scand J Gastroenterol; 2002 Apr 15; 37(4):437-43. PubMed ID: 11989835
    [Abstract] [Full Text] [Related]

  • 14. Acute responses of rat stomach enterochromaffinlike cells to gastrin: secretory activation and adaptation.
    Chen D, Monstein HJ, Nylander AG, Zhao CM, Sundler F, Håkanson R.
    Gastroenterology; 1994 Jul 15; 107(1):18-27. PubMed ID: 7517373
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
    Ding XQ, Lindström E, Håkanson R.
    Pharmacol Toxicol; 1997 Nov 15; 81(5):232-7. PubMed ID: 9396089
    [Abstract] [Full Text] [Related]

  • 16. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
    Norlén P, Lindström E, Ding XQ, Kitano M, Håkanson R.
    Pharmacol Toxicol; 1999 Apr 15; 84(4):159-64. PubMed ID: 10227066
    [Abstract] [Full Text] [Related]

  • 17. Reversibility of the cell kinetic changes induced by omeprazole in the rat oxyntic mucosa. An autoradiographic study using tritiated thymidine.
    Tielemans Y, Chen D, Sundler F, Håkanson R, Willems G.
    Scand J Gastroenterol; 1992 Apr 15; 27(2):155-60. PubMed ID: 1561530
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.